Intellectual Property and Access to Medicines : Affordability is a key determinant of access to medicines. Patents and other intellectual property rules can constitute a major barrier to access by creating market monopoliesRead More
According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, theRead More
The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against theRead More
Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population,Read More
Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis CRead More
November 30, 2013 – On the occasion of World AIDS Day 2013, HIV treatment activists from the MENA region called on wealthy Gulf States to join the Global Fund donor’s community sharing responsibilityRead More
